Compile Data Set for Download or QSAR

Found 1046 hits with Last Name = 'murray' and Initial = 'pj'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM50045179 ((R)-4-[2-(3,4-Dichloro-phenyl)-acetyl]-3-pyrrolidi...) Show SMILES COC(=O)N1CCN([C@@H](CN2CCCC2)C1)C(=O)Cc1ccc(Cl)c(Cl)c1 Show InChI InChI=1S/C19H25Cl2N3O3/c1-27-19(26)23-8-9-24(15(13-23)12-22-6-2-3-7-22)18(25)11-14-4-5-16(20)17(21)10-14/h4-5,10,15H,2-3,6-9,11-13H2,1H3/t15-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Similars	Article	n/a	n/a	0.0200	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Agonistic activity at kappa opioid receptor of rabbit vas deferens				Bioorg Med Chem Lett 2: 1275-1278 (1992) Article DOI: 10.1016/S0960-894X(00)80229-2 BindingDB Entry DOI: 10.7270/Q2125SKN
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM50280147 (1-[4-Acetyl-2-((S)-3-hydroxy-pyrrolidin-1-ylmethyl...) Show SMILES CC(=O)N1CCN(C(CN2CC[C@H](O)C2)C1)C(=O)Cc1ccc(Cl)c(Cl)c1 Show InChI InChI=1S/C19H25Cl2N3O3/c1-13(25)23-6-7-24(15(11-23)10-22-5-4-16(26)12-22)19(27)9-14-2-3-17(20)18(21)8-14/h2-3,8,15-16,26H,4-7,9-12H2,1H3/t15?,16-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article	n/a	n/a	0.220	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Agonistic activity at kappa opioid receptor of rabbit vas deferens				Bioorg Med Chem Lett 2: 1275-1278 (1992) Article DOI: 10.1016/S0960-894X(00)80229-2 BindingDB Entry DOI: 10.7270/Q2125SKN
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM142607 (US8933228, 14) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ncccc12)C(C)(C)C Show InChI InChI=1S/C30H28N8O4/c1-30(2,3)23-16-24(38(37-23)17-7-9-18(41-4)10-8-17)34-28(39)33-20-11-12-21(25-19(20)6-5-14-31-25)42-22-13-15-32-27-26(22)35-29(40)36-27/h5-16H,1-4H3,(H2,33,34,39)(H2,32,35,36,40)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.800	n/a	n/a	n/a	n/a	n/a	n/a
Respivert, Ltd. US Patent					Assay Description The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...				US Patent US8933228 (2015) BindingDB Entry DOI: 10.7270/Q2RV0MDW
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM142602 (US8933228, 4) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)n(n1)-c1ccccc1 Show InChI InChI=1S/C29H26N8O3/c1-29(2,3)22-16-23(37(36-22)17-8-5-4-6-9-17)33-27(38)32-19-11-12-20(24-18(19)10-7-14-30-24)40-21-13-15-31-26-25(21)34-28(39)35-26/h4-16H,1-3H3,(H2,32,33,38)(H2,31,34,35,39)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
Respivert, Ltd. US Patent					Assay Description The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...				US Patent US8933228 (2015) BindingDB Entry DOI: 10.7270/Q2RV0MDW
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM50280145 (1-[4-Acetyl-2-((S)-3-hydroxy-pyrrolidin-1-ylmethyl...) Show SMILES CC(=O)N1CCN(C(CN2CC[C@H](O)C2)C1)C(=O)Cc1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C20H29N3O5S/c1-15(24)22-9-10-23(17(13-22)12-21-8-7-18(25)14-21)20(26)11-16-3-5-19(6-4-16)29(2,27)28/h3-6,17-18,25H,7-14H2,1-2H3/t17?,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Agonistic activity at kappa opioid receptor of rabbit vas deferens				Bioorg Med Chem Lett 2: 1275-1278 (1992) Article DOI: 10.1016/S0960-894X(00)80229-2 BindingDB Entry DOI: 10.7270/Q2125SKN
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205308 (US9249125, 61) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CC(=O)Nc5c4)n3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)cc1 Show InChI InChI=1S/C41H41N9O5/c1-26(2)34-25-37(50(48-34)29-9-11-30(12-10-29)54-22-19-49-17-20-53-21-18-49)46-41(52)45-33-13-14-36(32-6-4-3-5-31(32)33)55-39-15-16-42-40(47-39)43-28-8-7-27-23-38(51)44-35(27)24-28/h3-16,24-26H,17-23H2,1-2H3,(H,44,51)(H,42,43,47)(H2,45,46,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205310 (US9249125, 63) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CNC(=O)c5c4)n3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)cc1 Show InChI InChI=1S/C42H43N9O5/c1-42(2,3)36-25-37(51(49-36)29-10-12-30(13-11-29)55-23-20-50-18-21-54-22-19-50)47-41(53)46-34-14-15-35(32-7-5-4-6-31(32)34)56-38-16-17-43-40(48-38)45-28-9-8-27-26-44-39(52)33(27)24-28/h4-17,24-25H,18-23,26H2,1-3H3,(H,44,52)(H,43,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM142601 (US8933228, 3) Show SMILES Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc3[nH]c(=O)n(C)c23)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C32H31N7O3/c1-19-10-12-20(13-11-19)39-27(18-26(37-39)32(2,3)4)35-30(40)34-23-14-15-24(22-9-7-6-8-21(22)23)42-25-16-17-33-29-28(25)38(5)31(41)36-29/h6-18H,1-5H3,(H,33,36,41)(H2,34,35,40)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Respivert, Ltd. US Patent					Assay Description The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...				US Patent US8933228 (2015) BindingDB Entry DOI: 10.7270/Q2RV0MDW
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247123 (3-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)N(C)CCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-28(2)37-27-39(52(49-37)32-12-10-29(3)11-13-32)47-43(54)46-36-14-15-38(35-9-7-6-8-34(35)36)57-40-16-17-44-42(48-40)45-31-24-30(25-33(26-31)55-5)41(53)50(4)18-19-51-20-22-56-23-21-51/h6-17,24-28H,18-23H2,1-5H3,(H,44,45,48)(H2,46,47,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247123 (3-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)N(C)CCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-28(2)37-27-39(52(49-37)32-12-10-29(3)11-13-32)47-43(54)46-36-14-15-38(35-9-7-6-8-34(35)36)57-40-16-17-44-42(48-40)45-31-24-30(25-33(26-31)55-5)41(53)50(4)18-19-51-20-22-56-23-21-51/h6-17,24-28H,18-23H2,1-5H3,(H,44,45,48)(H2,46,47,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247124 (1-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)N1CCN(C)CC1 Show InChI InChI=1S/C41H43N9O4/c1-26(2)35-25-37(50(47-35)30-12-10-27(3)11-13-30)45-41(52)44-34-14-15-36(33-9-7-6-8-32(33)34)54-38-16-17-42-40(46-38)43-29-22-28(23-31(24-29)53-5)39(51)49-20-18-48(4)19-21-49/h6-17,22-26H,18-21H2,1-5H3,(H,42,43,46)(H2,44,45,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247126 (3-((6-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)ncn2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H45N9O5/c1-27(2)36-24-39(51(49-36)31-11-9-28(3)10-12-31)48-42(53)47-35-13-14-37(34-8-6-5-7-33(34)35)56-40-25-38(44-26-45-40)46-30-21-29(22-32(23-30)54-4)41(52)43-15-16-50-17-19-55-20-18-50/h5-14,21-27H,15-20H2,1-4H3,(H,43,52)(H,44,45,46)(H2,47,48,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247127 (3-((6-((4-(3-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazo...) Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)ncn2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-28-10-12-31(13-11-28)52-39(25-37(50-52)43(2,3)4)49-42(54)48-35-14-15-36(34-9-7-6-8-33(34)35)57-40-26-38(45-27-46-40)47-30-22-29(23-32(24-30)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,47)(H2,48,49,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247085 (3-((4-((4-(3-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazo...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(ccc3OC)C(=O)NCCN(C)C)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C41H45N9O5/c1-41(2,3)35-25-36(50(48-35)27-13-15-28(53-6)16-14-27)46-40(52)45-31-17-19-33(30-11-9-8-10-29(30)31)55-37-20-21-43-39(47-37)44-32-24-26(12-18-34(32)54-7)38(51)42-22-23-49(4)5/h8-21,24-25H,22-23H2,1-7H3,(H,42,51)(H,43,44,47)(H2,45,46,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247086 (3-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1ccc(cc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H45N9O5/c1-27(2)34-26-38(51(49-34)30-12-9-28(3)10-13-30)47-42(53)46-33-14-16-36(32-8-6-5-7-31(32)33)56-39-17-18-44-41(48-39)45-35-25-29(11-15-37(35)54-4)40(52)43-19-20-50-21-23-55-24-22-50/h5-18,25-27H,19-24H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247088 (N-(2-hydroxyethyl)-3-((4-((4-(3-(3-isopropyl-1-(p-...) Show SMILES COc1ccc(cc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCO Show InChI InChI=1S/C38H38N8O5/c1-23(2)30-22-34(46(45-30)26-12-9-24(3)10-13-26)43-38(49)42-29-14-16-32(28-8-6-5-7-27(28)29)51-35-17-18-40-37(44-35)41-31-21-25(11-15-33(31)50-4)36(48)39-19-20-47/h5-18,21-23,47H,19-20H2,1-4H3,(H,39,48)(H,40,41,44)(H2,42,43,49)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247090 (N-(2-hydroxyethyl)-3-((4-((4-(3-(3-isopropyl-1-(4-...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(ccc3OC)C(=O)NCCO)n2)c2ccccc12)C(C)C Show InChI InChI=1S/C38H38N8O6/c1-23(2)30-22-34(46(45-30)25-10-12-26(50-3)13-11-25)43-38(49)42-29-14-16-32(28-8-6-5-7-27(28)29)52-35-17-18-40-37(44-35)41-31-21-24(9-15-33(31)51-4)36(48)39-19-20-47/h5-18,21-23,47H,19-20H2,1-4H3,(H,39,48)(H,40,41,44)(H2,42,43,49)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247091 (N-(2-(dimethylamino)ethyl)-4-((4-((4-(3-(3-isoprop...) Show SMILES COc1cc(ccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCN(C)C Show InChI InChI=1S/C40H43N9O4/c1-25(2)33-24-36(49(47-33)28-14-11-26(3)12-15-28)45-40(51)44-31-17-18-34(30-10-8-7-9-29(30)31)53-37-19-20-42-39(46-37)43-32-16-13-27(23-35(32)52-6)38(50)41-21-22-48(4)5/h7-20,23-25H,21-22H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247091 (N-(2-(dimethylamino)ethyl)-4-((4-((4-(3-(3-isoprop...) Show SMILES COc1cc(ccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCN(C)C Show InChI InChI=1S/C40H43N9O4/c1-25(2)33-24-36(49(47-33)28-14-11-26(3)12-15-28)45-40(51)44-31-17-18-34(30-10-8-7-9-29(30)31)53-37-19-20-42-39(46-37)43-32-16-13-27(23-35(32)52-6)38(50)41-21-22-48(4)5/h7-20,23-25H,21-22H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247100 (3-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1ccc(C)cc1 Show InChI InChI=1S/C42H45N9O4/c1-27(2)36-26-38(51(49-36)32-11-9-28(3)10-12-32)47-42(53)46-35-13-14-37(34-8-6-5-7-33(34)35)55-39-15-16-44-41(48-39)45-31-24-29(4)23-30(25-31)40(52)43-17-18-50-19-21-54-22-20-50/h5-16,23-27H,17-22H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247104 (3-((4-((4-(3-(3-ethyl-1-(p-tolyl)-1H-pyrazol-5-yl)...) Show SMILES CCc1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1ccc(C)cc1 Show InChI InChI=1S/C41H43N9O5/c1-4-29-26-37(50(48-29)31-11-9-27(2)10-12-31)46-41(52)45-35-13-14-36(34-8-6-5-7-33(34)35)55-38-15-16-43-40(47-38)44-30-23-28(24-32(25-30)53-3)39(51)42-17-18-49-19-21-54-22-20-49/h5-16,23-26H,4,17-22H2,1-3H3,(H,42,51)(H,43,44,47)(H2,45,46,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247105 (3-((4-((4-(3-(3-cyclopropyl-1-(p-tolyl)-1H-pyrazol...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C4CC4)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H43N9O5/c1-27-7-11-31(12-8-27)51-38(26-36(49-51)28-9-10-28)47-42(53)46-35-13-14-37(34-6-4-3-5-33(34)35)56-39-15-16-44-41(48-39)45-30-23-29(24-32(25-30)54-2)40(52)43-17-18-50-19-21-55-22-20-50/h3-8,11-16,23-26,28H,9-10,17-22H2,1-2H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247106 (3-methoxy-5-((4-((4-(3-(3-(1-methylcyclopropyl)-1-...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C4(C)CC4)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H45N9O5/c1-28-8-10-31(11-9-28)52-38(27-37(50-52)43(2)15-16-43)48-42(54)47-35-12-13-36(34-7-5-4-6-33(34)35)57-39-14-17-45-41(49-39)46-30-24-29(25-32(26-30)55-3)40(53)44-18-19-51-20-22-56-23-21-51/h4-14,17,24-27H,15-16,18-23H2,1-3H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247108 (3-((4-((4-(3-(3-isopropyl-1-(4-methoxyphenyl)-1H-p...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(OC)cc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C(C)C Show InChI InChI=1S/C42H45N9O6/c1-27(2)36-26-38(51(49-36)30-9-11-31(54-3)12-10-30)47-42(53)46-35-13-14-37(34-8-6-5-7-33(34)35)57-39-15-16-44-41(48-39)45-29-23-28(24-32(25-29)55-4)40(52)43-17-18-50-19-21-56-22-20-50/h5-16,23-27H,17-22H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247111 (3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-27(2)37-26-39(52(50-37)32-11-10-28(3)29(4)22-32)48-43(54)47-36-12-13-38(35-9-7-6-8-34(35)36)57-40-14-15-45-42(49-40)46-31-23-30(24-33(25-31)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247112 (3-((4-((4-(3-(3-(tert-butyl)-1-(6-methoxypyridin-3...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)nc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H46N10O6/c1-42(2,3)35-25-36(52(50-35)29-10-13-37(56-5)45-26-29)48-41(54)47-33-11-12-34(32-9-7-6-8-31(32)33)58-38-14-15-44-40(49-38)46-28-22-27(23-30(24-28)55-4)39(53)43-16-17-51-18-20-57-21-19-51/h6-15,22-26H,16-21H2,1-5H3,(H,43,53)(H,44,46,49)(H2,47,48,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247113 (3-methoxy-5-((4-((4-(3-(1-(4-methoxyphenyl)-3-(tet...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(OC)cc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1CCCO1 Show InChI InChI=1S/C43H45N9O7/c1-55-31-11-9-30(10-12-31)52-39(27-36(50-52)38-8-5-21-58-38)48-43(54)47-35-13-14-37(34-7-4-3-6-33(34)35)59-40-15-16-45-42(49-40)46-29-24-28(25-32(26-29)56-2)41(53)44-17-18-51-19-22-57-23-20-51/h3-4,6-7,9-16,24-27,38H,5,8,17-23H2,1-2H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247113 (3-methoxy-5-((4-((4-(3-(1-(4-methoxyphenyl)-3-(tet...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(OC)cc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1CCCO1 Show InChI InChI=1S/C43H45N9O7/c1-55-31-11-9-30(10-12-31)52-39(27-36(50-52)38-8-5-21-58-38)48-43(54)47-35-13-14-37(34-7-4-3-6-33(34)35)59-40-15-16-45-42(49-40)46-29-24-28(25-32(26-29)56-2)41(53)44-17-18-51-19-22-57-23-20-51/h3-4,6-7,9-16,24-27,38H,5,8,17-23H2,1-2H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247114 (3-methoxy-5-((4-((4-(3-(1-(4-methoxyphenyl)-3-(tet...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(OC)cc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1CCOC1 Show InChI InChI=1S/C43H45N9O7/c1-55-32-9-7-31(8-10-32)52-39(26-37(50-52)28-14-20-58-27-28)48-43(54)47-36-11-12-38(35-6-4-3-5-34(35)36)59-40-13-15-45-42(49-40)46-30-23-29(24-33(25-30)56-2)41(53)44-16-17-51-18-21-57-22-19-51/h3-13,15,23-26,28H,14,16-22,27H2,1-2H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247059 (3-((4-((4-(3-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazo...) Show SMILES Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C42H45N9O4/c1-28-12-14-31(15-13-28)51-37(27-36(49-51)42(2,3)4)47-41(53)46-34-16-17-35(33-11-6-5-10-32(33)34)55-38-18-19-44-40(48-38)45-30-9-7-8-29(26-30)39(52)43-20-21-50-22-24-54-25-23-50/h5-19,26-27H,20-25H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247061 (N-(2-(Dimethylamino)ethyl)-3-((4-((4-(3-(3-isoprop...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN(C)C Show InChI InChI=1S/C40H43N9O4/c1-25(2)34-24-36(49(47-34)29-13-11-26(3)12-14-29)45-40(51)44-33-15-16-35(32-10-8-7-9-31(32)33)53-37-17-18-42-39(46-37)43-28-21-27(22-30(23-28)52-6)38(50)41-19-20-48(4)5/h7-18,21-25H,19-20H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247062 (N-(2-(Dimethylamino)ethyl)-3-((4-((4-(3-(3-isoprop...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(OC)cc(c3)C(=O)NCCN(C)C)n2)c2ccccc12)C(C)C Show InChI InChI=1S/C40H43N9O5/c1-25(2)34-24-36(49(47-34)28-11-13-29(52-5)14-12-28)45-40(51)44-33-15-16-35(32-10-8-7-9-31(32)33)54-37-17-18-42-39(46-37)43-27-21-26(22-30(23-27)53-6)38(50)41-19-20-48(3)4/h7-18,21-25H,19-20H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247064 (3-((4-((4-(3-(3-Isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H45N9O5/c1-27(2)36-26-38(51(49-36)31-11-9-28(3)10-12-31)47-42(53)46-35-13-14-37(34-8-6-5-7-33(34)35)56-39-15-16-44-41(48-39)45-30-23-29(24-32(25-30)54-4)40(52)43-17-18-50-19-21-55-22-20-50/h5-16,23-27H,17-22H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247070 (3-((6-((4-(3-(3-isopropyl-1-(4-methoxyphenyl)-1H-p...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2cc(Nc3cc(OC)cc(c3)C(=O)NCCN3CCOCC3)ncn2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C43H47N9O6/c1-43(2,3)37-25-39(52(50-37)30-10-12-31(55-4)13-11-30)49-42(54)48-35-14-15-36(34-9-7-6-8-33(34)35)58-40-26-38(45-27-46-40)47-29-22-28(23-32(24-29)56-5)41(53)44-16-17-51-18-20-57-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,47)(H2,48,49,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247078 (3-((4-((4-(3-(3-(3-methyloxetan-3-yl)-1-(p-tolyl)-...) Show SMILES Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1(C)COC1 Show InChI InChI=1S/C42H43N9O5/c1-28-10-12-31(13-11-28)51-37(25-36(49-51)42(2)26-55-27-42)47-41(53)46-34-14-15-35(33-9-4-3-8-32(33)34)56-38-16-17-44-40(48-38)45-30-7-5-6-29(24-30)39(52)43-18-19-50-20-22-54-23-21-50/h3-17,24-25H,18-23,26-27H2,1-2H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247078 (3-((4-((4-(3-(3-(3-methyloxetan-3-yl)-1-(p-tolyl)-...) Show SMILES Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1(C)COC1 Show InChI InChI=1S/C42H43N9O5/c1-28-10-12-31(13-11-28)51-37(25-36(49-51)42(2)26-55-27-42)47-41(53)46-34-14-15-35(33-9-4-3-8-32(33)34)56-38-16-17-44-40(48-38)45-30-7-5-6-29(24-30)39(52)43-18-19-50-20-22-54-23-21-50/h3-17,24-25H,18-23,26-27H2,1-2H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247079 (3-((4-((4-(3-(1-(4-methoxyphenyl)-3-(3-methyloxeta...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1(C)COC1 Show InChI InChI=1S/C42H43N9O6/c1-42(26-56-27-42)36-25-37(51(49-36)30-10-12-31(54-2)13-11-30)47-41(53)46-34-14-15-35(33-9-4-3-8-32(33)34)57-38-16-17-44-40(48-38)45-29-7-5-6-28(24-29)39(52)43-18-19-50-20-22-55-23-21-50/h3-17,24-25H,18-23,26-27H2,1-2H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247079 (3-((4-((4-(3-(1-(4-methoxyphenyl)-3-(3-methyloxeta...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C1(C)COC1 Show InChI InChI=1S/C42H43N9O6/c1-42(26-56-27-42)36-25-37(51(49-36)30-10-12-31(54-2)13-11-30)47-41(53)46-34-14-15-35(33-9-4-3-8-32(33)34)57-38-16-17-44-40(48-38)45-29-7-5-6-28(24-29)39(52)43-18-19-50-20-22-55-23-21-50/h3-17,24-25H,18-23,26-27H2,1-2H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247080 (3-((4-((4-(3-(3-(tert-butyl)-1-(4-methylthiophen-2...) Show SMILES Cc1csc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(c3)C(=O)NCCN3CCOCC3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C40H43N9O4S/c1-26-22-36(54-25-26)49-34(24-33(47-49)40(2,3)4)45-39(51)44-31-12-13-32(30-11-6-5-10-29(30)31)53-35-14-15-42-38(46-35)43-28-9-7-8-27(23-28)37(50)41-16-17-48-18-20-52-21-19-48/h5-15,22-25H,16-21H2,1-4H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247084 (N-(2-(dimethylamino)ethyl)-3-((4-((4-(3-(3-isoprop...) Show SMILES COc1ccc(cc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCN(C)C Show InChI InChI=1S/C40H43N9O4/c1-25(2)32-24-36(49(47-32)28-14-11-26(3)12-15-28)45-40(51)44-31-16-18-34(30-10-8-7-9-29(30)31)53-37-19-20-42-39(46-37)43-33-23-27(13-17-35(33)52-6)38(50)41-21-22-48(4)5/h7-20,23-25H,21-22H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247084 (N-(2-(dimethylamino)ethyl)-3-((4-((4-(3-(3-isoprop...) Show SMILES COc1ccc(cc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)C)c3ccccc23)n1)C(=O)NCCN(C)C Show InChI InChI=1S/C40H43N9O4/c1-25(2)32-24-36(49(47-32)28-14-11-26(3)12-15-28)45-40(51)44-31-16-18-34(30-10-8-7-9-29(30)31)53-37-19-20-42-39(46-37)43-33-23-27(13-17-35(33)52-6)38(50)41-21-22-48(4)5/h7-20,23-25H,21-22H2,1-6H3,(H,41,50)(H,42,43,46)(H2,44,45,51)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247085 (3-((4-((4-(3-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazo...) Show SMILES COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(ccc3OC)C(=O)NCCN(C)C)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C41H45N9O5/c1-41(2,3)35-25-36(50(48-35)27-13-15-28(53-6)16-14-27)46-40(52)45-31-17-19-33(30-11-9-8-10-29(30)31)55-37-20-21-43-39(47-37)44-32-24-26(12-18-34(32)54-7)38(51)42-22-23-49(4)5/h8-21,24-25H,22-23H2,1-7H3,(H,42,51)(H,43,44,47)(H2,45,46,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM205337 (US9249125, 90) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CC(=O)Nc5c4)n3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)nc1 Show InChI InChI=1S/C41H42N10O5/c1-41(2,3)34-24-35(51(49-34)28-10-13-37(43-25-28)55-21-18-50-16-19-54-20-17-50)47-40(53)46-31-11-12-33(30-7-5-4-6-29(30)31)56-38-14-15-42-39(48-38)44-27-9-8-26-22-36(52)45-32(26)23-27/h4-15,23-25H,16-22H2,1-3H3,(H,45,52)(H,42,44,48)(H2,46,47,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM205338 (US9249125, 91) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OCCN5CCOCC5)nc4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C41H43N11O4/c1-26-21-28(22-27-24-44-49-38(26)27)45-39-42-14-13-37(48-39)56-33-11-10-32(30-7-5-6-8-31(30)33)46-40(53)47-35-23-34(41(2,3)4)50-52(35)29-9-12-36(43-25-29)55-20-17-51-15-18-54-19-16-51/h5-14,21-25H,15-20H2,1-4H3,(H,44,49)(H,42,45,48)(H2,46,47,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM205339 (US9249125, 92) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5n(CCN6CCOCC6)ncc5c4)n3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)nc1 Show InChI InChI=1S/C46H52N12O5/c1-46(2,3)40-29-41(58(54-40)34-9-13-42(48-31-34)62-27-22-56-20-25-61-26-21-56)52-45(59)51-37-10-12-39(36-7-5-4-6-35(36)37)63-43-14-15-47-44(53-43)50-33-8-11-38-32(28-33)30-49-57(38)17-16-55-18-23-60-24-19-55/h4-15,28-31H,16-27H2,1-3H3,(H,47,50,53)(H2,51,52,59)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM205305 (US9249125, 58) Show SMILES CN(C)CCOc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)c2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C41H43N9O3/c1-26-21-28(22-27-25-43-47-39(26)27)44-37-23-31(17-18-42-37)53-35-16-15-34(32-9-7-8-10-33(32)35)45-40(51)46-38-24-36(41(2,3)4)48-50(38)29-11-13-30(14-12-29)52-20-19-49(5)6/h7-18,21-25H,19-20H2,1-6H3,(H,42,44)(H,43,47)(H2,45,46,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the l...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM50156158 (CHEMBL3781244) Show SMILES CN(C)CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 Show InChI InChI=1S/C35H39N7O3/c1-23-11-13-25(14-12-23)42-32(20-30(40-42)35(2,3)4)39-34(44)37-28-15-16-29(27-10-8-7-9-26(27)28)45-22-24-17-18-36-31(19-24)38-33(43)21-41(5)6/h7-20H,21-22H2,1-6H3,(H,36,38,43)(H2,37,39,44)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Sygnature Discovery Limited Curated by ChEMBL					Assay Description Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addi...				J Med Chem 59: 1727-46 (2016) Article DOI: 10.1021/acs.jmedchem.5b01029 BindingDB Entry DOI: 10.7270/Q2319XRB
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205314 (US9249125, 67) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)cc1 Show InChI InChI=1S/C42H43N9O4/c1-42(2,3)38-26-40(51(49-38)30-9-11-31(12-10-30)54-23-20-50-18-21-53-22-19-50)47-41(52)46-36-14-15-37(34-7-5-4-6-33(34)36)55-32-16-17-43-39(25-32)45-29-8-13-35-28(24-29)27-44-48-35/h4-17,24-27H,18-23H2,1-3H3,(H,43,45)(H,44,48)(H2,46,47,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205321 (US9249125, 74) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5n(CCN6CCOCC6)ncc5c4)n3)c3ccccc23)n(n1)-c1ccc(OCCN2CCOCC2)cc1 Show InChI InChI=1S/C47H53N11O5/c1-47(2,3)42-31-43(58(54-42)35-9-11-36(12-10-35)62-29-24-56-22-27-61-28-23-56)52-46(59)51-39-13-15-41(38-7-5-4-6-37(38)39)63-44-16-17-48-45(53-44)50-34-8-14-40-33(30-34)32-49-57(40)19-18-55-20-25-60-26-21-55/h4-17,30-32H,18-29H2,1-3H3,(H,48,50,53)(H2,51,52,59)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205322 (US9249125, 75) Show SMILES Cc1nc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(nn5-c5ccc(OCCN6CCOCC6)cc5)C(C)(C)C)c5ccccc45)n3)ccc2[nH]1 Show InChI InChI=1S/C42H44N10O4/c1-27-44-34-14-9-28(25-35(34)45-27)46-40-43-18-17-39(49-40)56-36-16-15-33(31-7-5-6-8-32(31)36)47-41(53)48-38-26-37(42(2,3)4)50-52(38)29-10-12-30(13-11-29)55-24-21-51-19-22-54-23-20-51/h5-18,25-26H,19-24H2,1-4H3,(H,44,45)(H,43,46,49)(H2,47,48,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1046 total )  |  Next  |  Last  >>

Jump to: